Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VBI 1901

Next Previous
Search
Drug Profile

VBI 1901

Alternative Names: eVLP vaccines - VBI Vaccines; GBM eVLP - VBI; Glioblastoma eVLP Vaccine - VBI Vaccines; Glioblastoma Immunotherapy; MB therapeutic vaccine candidate; Medulloblastoma eVLP Vaccine - VBI Vaccines; Medulloblastoma therapeutic vaccine candidate; VBI-1901

Latest Information Update: 14 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator VBI Vaccines
  • Developer GSK; VBI Vaccines
  • Class Antineoplastics; Cancer vaccines; Immunotherapies; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glioblastoma
  • New Molecular Entity No

Highest Development Phases

  • Phase II Glioblastoma
  • No development reported Medulloblastoma

Most Recent Events

  • 31 May 2024 Adverse events data from a phase-I/II trial in Glioblastoma presented at the 60th Annual Meeting of the American Society of Clinical Oncology (ASCO-2024)
  • 29 May 2024 Efficacy data from a phase IIb trial in Glioblastoma released by VBI Vaccines
  • 03 Apr 2024 Efficacy data from a phase IIb trial in Glioblastoma released by VBI Vaccines

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top